Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion

JAMA Intern Med. 2013 Mar 25;173(6):475-6. doi: 10.1001/jamainternmed.2013.2176.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Female
  • HIV Infections / drug therapy*
  • HIV Seropositivity / drug therapy*
  • HIV-1 / immunology*
  • Humans
  • Male

Substances

  • Anti-Retroviral Agents